Olympic testing
HFL Sport Science (HFL), a part of the LGC Group (Teddington, Middlesex, UK) and one of the world’s largest sports drug surveillance laboratories, is preparing for its role testing the horses competing in equestrian events at the Olympic and Paralympic Games.
HFL Sport Science (HFL), a part of the LGC Group (Teddington, Middlesex, UK) and one of the world’s largest sports drug surveillance laboratories, is preparing for its role testing the horses competing in equestrian events at the Olympic and Paralympic Games.
HFL screens for approximately 2,000 different prohibited substances in each urine or blood sample taken from competing animals. This service is delivered within a Quality System framework that is externally accredited to the ISO 17025 Standard for Testing and Calibration Laboratories. The company has nearly 50 years’ experience in the science of sports doping control, including experience testing within the framework of the World Anti-Doping Agency (WADA) and testing human and animal food supplements for substances prohibited in sport.
Jeremy Cook, managing director of the LGC Health Sciences Division, commented: “We are very proud to be playing a small but important role in the London 2012 Olympic and Paralympic Games. We are confident that our experienced scientists and technology will enable us to meet the exacting standards required for such an important and prestigious event.”
For more information please visit www.lgc.co.uk
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
